These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 13979)
1. Metabolism of sudoxicam by the rat, dog, and monkey. Hobbs DC; Twomey TM Drug Metab Dispos; 1977; 5(1):75-81. PubMed ID: 13979 [TBL] [Abstract][Full Text] [Related]
2. Metabolic disposition of isoxicam in man, monkey, dog, and rat. Borondy PE; Michniewicz BM Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of 4-(3-(dimethylamino)propyl)-3,4-dihydro-2-(1-hydroxyethyl)-3-phenyl-2H-1,4-benzothiazine (SQ 11,579) under in vitro and in vivo conditions by rats, dogs, and monkey. Lan SJ; Chando TJ; Cohen AI; Weliky I; Schreiber EC Drug Metab Dispos; 1973; 1(4):619-27. PubMed ID: 4149635 [No Abstract] [Full Text] [Related]
4. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related]
5. Comparative metabolism of fenclorac in rat, dog, monkey, and man. DeLong AF; Smyth RD; Polk A; Nayak RK; Martin G; Douglas GH; Reavey-Cantiwell NH Drug Metab Dispos; 1977; 5(2):122-31. PubMed ID: 15804 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of piroxicam by laboratory animals. Hobbs DC; Twomey TM Drug Metab Dispos; 1981; 9(2):114-8. PubMed ID: 6113108 [TBL] [Abstract][Full Text] [Related]
7. In vivo metabolism of isoxicam in rats, dogs, and monkeys. Woolf TF; Black A; Hicks JL; Lee H; Huang CC; Chang T Drug Metab Dispos; 1989; 17(6):662-8. PubMed ID: 2575504 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys. Siefert HM; Maruhn D; Maul W; Förster D; Ritter W Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211 [TBL] [Abstract][Full Text] [Related]
9. Excretion and metabolism of a nonsteroidal antiinflammatory agent, 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, in rat, dog, monkey, and man. Chiaini J; Wiseman EH; Lombardino JG J Med Chem; 1971 Dec; 14(12):1175-7. PubMed ID: 5000562 [No Abstract] [Full Text] [Related]
10. Metabolism of labetalol by animals and man. Martin LE; Hopkins R; Bland R Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152 [TBL] [Abstract][Full Text] [Related]
11. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676 [TBL] [Abstract][Full Text] [Related]
12. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948 [TBL] [Abstract][Full Text] [Related]
13. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs. Prakash C; Cui D; Potchoiba MJ; Butler T Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences. Lan SJ; El-Hawey AM; Dean AV; Schreiber EC Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816 [TBL] [Abstract][Full Text] [Related]
15. Disposition of [14C]velnacrine maleate in rats, dogs, and humans. Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382 [TBL] [Abstract][Full Text] [Related]
16. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees. Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025 [TBL] [Abstract][Full Text] [Related]
17. Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man. Hucker HB; Stauffer SC; Balletto AJ; White SD; Zacchei AG; Arison BH Drug Metab Dispos; 1978; 6(6):659-72. PubMed ID: 33029 [TBL] [Abstract][Full Text] [Related]
18. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals. Chen IW; Lin JH Drug Metab Dispos; 1994; 22(5):693-9. PubMed ID: 7835219 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845 [TBL] [Abstract][Full Text] [Related]
20. Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys. Hucker HB; Hutt JE; White SD; Arison BH; Zacchei AG Drug Metab Dispos; 1983; 11(1):54-8. PubMed ID: 6132797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]